Nu-Med Plus, Inc.
NUMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | 50% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $10 | $10 | $19 | $9 |
| SG&A Expenses | $10 | $10 | $19 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $10 | $19 | $9 |
| Operating Income | $0 | -$10 | -$19 | -$9 |
| % Margin | – | – | – | -1,549% |
| Other Income/Exp. Net | $0 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$12 | -$12 | -$20 | -$11 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$12 | -$20 | -$11 |
| % Margin | – | – | – | -1,759.2% |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | 0% | 50% | -100% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 83,548 | 83,548 | 83,548 | 83,548 |
| Weighted Avg Shares Out Dil | 83,548 | 83,548 | 83,548 | 83,548 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $19 | $9 |
| EBITDA | -$10 | -$10 | $0 | $0 |
| % Margin | – | – | – | 0% |